The newly formed Genetic Medicine Technology group in gRED (Genentech Research and Early Development) is redefining the future of cell and gene therapies. Our proprietary non-viral gene delivery and gene editing platforms, including piggyBac® and Cas-CLOVER™, enable the development of next-generation CAR-T therapies with the potential to cure cancer and genetic diseases. We are seeking a highly motivated and innovative Scientist 3 with a strong background in immunology and CAR-T cell therapy to join our dynamic research team. This individual will lead efforts in screening novel CAR constructs, executing functional assays, and evaluating efficacy in preclinical in vivo models. The ideal candidate will have hands-on experience with LNP transduction, flow cytometry, cytokine profiling, and mouse tumor models, and will serve as a Principal Investigator (PI) on in vivo studies.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
Ph.D. or professional degree
Number of Employees
251-500 employees